middle.news
How AdAlta’s New Canadian Patent Completes AD-214’s Global Protection Puzzle
10:00am on Friday 20th of March, 2026 AEDT
•
Biotechnology
Read Story
How AdAlta’s New Canadian Patent Completes AD-214’s Global Protection Puzzle
10:00am on Friday 20th of March, 2026 AEDT
Key Points
Canadian composition of matter patent granted for AD-214
Patent protection now secured in US, Canada, EU, Japan, India, and China
Patent expiry set for January 2036 with potential extensions to 2043
AD-214 targets fibrotic diseases including Idiopathic Pulmonary Fibrosis and kidney fibrosis
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE